Liquid antisolvent precipitation process for solubility modulation of bicalutamide

D. R. Vega, G. Polla, A. Martinez, E. Mendioroz and M. Reionoso, Conformational polymorphism in bicalutamide, Int. J. Pharm. 328 (2007) 112-118; DOI: 10.1016/j.ijpharm.2006.08.001.10.1016/j.ijpharm.2006.08.00116978811Search in Google Scholar

D. Wu, J. Yang, V. A. Nair, D. D. Miller and J. T. Dalton, Pharmacokinetics and metabolism of a selective androgen receptor modulator in rats: implication of molecular properties and intensive metabolic profile to investigate ideal pharmacokinetic chrecteristics of a propanamide in preclinical study, Drug Metab. Dispos. 34 (2006) 483-494; DOI: 10.1124/dmd.105.006643.10.1124/dmd.105.006643203987716381665Search in Google Scholar

Y. Le, H. Ji, J. F. Chen, Z. Shen, J. Yun and M. Pu, Nanosized bicalutamide and its molecular structure in solvents, Int. J. Pharm. 370 (2009) 175-180; DOI: 10.1016/j.ijpharm.2008.11.025.10.1016/j.ijpharm.2008.11.02519101616Search in Google Scholar

A. Abdalla and K. Mäder, Preparation and characterization of a self-emulsifying pellet formulation, Eur. J. Pharm. Biopharm. 66 (2007) 220-226; DOI: 10.1016/j.ejpb.2006.11.015.10.1016/j.ejpb.2006.11.01517196807Search in Google Scholar

I. Kanfer, Report on the international workshop on the biopharmaceutics classification system (BCS): scientific and regulatory aspects in practice, J. Pharm. Pharm. Sci. 5 (2000) 1-4.Search in Google Scholar

P. Kocbek, S. Baumgartner and J. Kristl, Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs, Int. J. Pharm. 312 (2006) 179-186; DOI: 10.1016/j.ijpharm.2006.01.008.10.1016/j.ijpharm.2006.01.00816469459Search in Google Scholar

Y. Dong, W. N. Kiong, S. Shen, S. Kim and R. B. H. Tan, Preparation and characterization of spironolactone nanoparticles by antisolvent precipitation, Int. J. Pharm. 375 (2009) 84-88; DOI: 10.1016/j.ijpharm.2009.03.013.10.1016/j.ijpharm.2009.03.01319481693Search in Google Scholar

A. Balakrishnan, B. D. Rege, G. L. Amidon and J. E. Polli, Surfactant-mediated dissolution: contributions of solubility enhancement and relatively low micelle diffusivity, J. Pharm. Sci. 93 (2004) 2064-2075; DOI: 10.1002/jps.20118.10.1002/jps.2011815236455Search in Google Scholar

G. S. Jadhav and P. R. Vavia, Physicochemical in silico and in-vivo evaluation of danazole-β-cyclodextrin complex, Int. J. Pharm. 352 (2008) 5-16 DOI: 10.1016/j.ijpharm.2007.10.005.10.1016/j.ijpharm.2007.10.00518023545Search in Google Scholar

I. Ilić, R. Dreu, M. Burjak, M. Homar, J. Kerč and J. S. Srčič, Microparticle size control and glimepiride microencapsulation using spray congealing technology, Int. J. Pharm. 381 (2009) 176-183; DOI: 10.1016/j.ijpharm.2009.05.011.10.1016/j.ijpharm.2009.05.01119446625Search in Google Scholar

M. D. Moore and P. L. D. Wildfong, Aqueous solubility enhancement through engineering of binary solid composites: pharmaceutical applications, J. Pharm. Innov. 4 (2009) 36-49; DOI: 10.1007/s12247-009-9053-7.10.1007/s12247-009-9053-7Search in Google Scholar

P. Zhang, H. Ye, T. Min and C. Zhang, Water soluble poly(ethylene glycol) prodrug of silybin: design, synthesis, and characterization, J. Appl. Polym. Sci. 107 (2008) 3230-3235; DOI: 10.1002/app.27450.10.1002/app.27450Search in Google Scholar

Y. Le, H. Ji, J. Chen, Z. Shen, J. Yun and M. Pu, Nanosized bicalutamide and its molecular structure in solvents, Int. J. Pharm. 370 (2009) 175-180 DOI: 10.1016/j.ijpharm.2008.11.025.10.1016/j.ijpharm.2008.11.02519101616Search in Google Scholar

R. P. Bagwe and K. C. Khilar, Effects of the intermicellar exchange rate and cations on the size of silver chloride nanoparticles formed in reverse micelles of AOT, Langmuir 13 (1997) 6432-6438; DOI: 10.1021/la980248q.10.1021/la980248qSearch in Google Scholar

J. Y. Zhang, Z. G. Shen, J. Zhong, T. T. Hu, J. F. Chen, Z. Q. Ma and J. Yun, Preparation of amorphous cefuroxime axetil nanoparticles by controlled nanoprecipitation method without surfactants, Int. J. Pharm. 323 (2006) 153-160; DOI: 10.1016/i.ijpharm.2006.05.048.Search in Google Scholar

U. S. Food and Drug Administration, Dissolution Methods, Bicalutamide, FDA, Silver Sping (MD), Dec 15 2005; http://www.accessdata.fda.(MD)gov/scripts/cder/dissolution/dsp_Search-Results_Dissolutions.cfm?PrintAll=1Search in Google Scholar